EORTC protocol 24863

Phase II Randomized Chemotherapy Trial of CHIP vs CACP in Patients with Advanced Ovarian Cancer Refractory or Recurrent After First-Line Chemotherapy with CBDCA (Summary Last Modified 05/88
Trial StatusAll trial activities ended
DatesDate of activation: 15-Oct-86
Closed on : 15-Nov-87
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size14
Number of steps1
Drug
Study StaffJan Herman Schornagel (Study Coordinator) - The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section